Overview
Description
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions organization, primarily engaged in providing clinical development services. The company plays a critical role in the pharmaceutical industry by delivering a comprehensive suite of services including clinical trials management, commercialization advisory, and biopharmaceutical consulting services. Its operations are pivotal in helping pharmaceutical companies accelerate the drug development process, thereby facilitating quicker access to therapeutic innovations. Syneos Health's services extend over a broad spectrum of therapeutic areas and stages of drug development, harnessing a global team of professionals with specialized expertise. With a focus on end-to-end service delivery, Syneos Health enhances project efficiency, ensuring regulatory compliance and optimizing clinical performance. Its contributions significantly impact the healthcare sector by fostering innovation, reducing time-to-market for new therapies, and supporting the development of cutting-edge treatments. Through strategic partnerships and its commitment to scientific excellence, Syneos Health maintains a pivotal role in advancing global health outcomes and strengthening the biopharmaceutical supply chain.
About
CEO
Dr. Ilham Kadri Ph.D.
Employees
12686
Address
Rue de la Fusée 98
Brussels, 1130
Brussels, 1130
Phone
32 2 264 19 00
Website
Instrument type
Common stock
Sector
Basic Materials
Industry
Chemicals
Country
Belgium
MIC code
XBRU